Eden Research plc (LON:EDEN – Get Free Report) traded up 11.9% during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as GBX 4.12 ($0.05) and last traded at GBX 4.03 ($0.05). 11,524,709 shares traded hands during trading, an increase of 638% from the average session volume of 1,562,568 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Trading Up 11.9 %
The stock has a fifty day moving average of GBX 3.88 and a 200 day moving average of GBX 4.02. The company has a debt-to-equity ratio of 1.25, a quick ratio of 2.42 and a current ratio of 3.80. The company has a market capitalization of £21.49 million, a P/E ratio of -200.00 and a beta of 0.92.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- Most active stocks: Dollar volume vs share volume
- What Does the Future Hold for Eli Lilly?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
